series-a
Stage
1
Investors
About
Exai Bio is a next-generation liquid biopsy company that utilizes RNA biomarkers and artificial intelligence to deliver clinical insights into cancer biology, enabling early and accurate cancer detection through non-invasive blood tests.
Explore Exai Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.